Biodiversity Interventions for Well-Being
BIWE
3 other identifiers
interventional
30
1 country
1
Brief Summary
Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities, which weakens the functionality of the urban ecosystems and the well-being of citizens. This may also increase the risk of immune-mediated disorders among urban dwellers. In Biodiversity interventions for well-being (BIWE), microbial biodiversity interventions are performed to increase biodiversity in urban built areas. Results from the intervention trials are combined with publicly available land cover and ecological data. These are analyzed from the viewpoint of shifts in ecosystems and human well-being and immune regulation, ecological quality, and urban planning. The investigators set up an intervention study in which urban private yards are rewilded with diverse vegetation and decaying deadwood and plant residuals. The investigators aim to evaluate the effect of rewilding, and yard management practices on commensal microbiome, cortisol levels and well-being and salivary cytokine levels, and gene pathways.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2022
CompletedFirst Submitted
Initial submission to the registry
March 27, 2024
CompletedFirst Posted
Study publicly available on registry
April 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2027
April 8, 2024
March 1, 2024
5.3 years
March 27, 2024
April 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Skin Gammaproteobacteria
Difference on skin gammaproteobacterial diversity between rewilding and control group
Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Outcomes (11)
Salivary cytokines
Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Difference in diversity (Alpha and beta diversity) of skin, saliva and stool microbiota
Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Difference in observed species richness of skin, saliva and stool microbiota
Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Difference in taxonomies of skin, saliva and stool microbiota
Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Difference in microbial gene pathways of saliva and stool microbiota
Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
- +6 more secondary outcomes
Other Outcomes (1)
Associations between environmental factors and microbial measurements, salivary cytokine levels, hair cortisol levels, perceived well-being
Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Study Arms (2)
Rewilding
EXPERIMENTALPrivate yards of the intervention study subjects will be modified with berry bushes, fruit trees, perennial yard plants, meadow flowers, cultivation boxes, organic mulch materials, decaying deadwood, leaf compost and organic plant growing media with high microbial diversity.
Control
NO INTERVENTIONThe control group's yards will not be modified. Control group receives inorganic fertilizers, moss remover and ant control insecticide (Myrr®; active ingredient imidacloprid 0.03 % w/w).
Interventions
Private yards of the intervention study subjects will be modified with vegetation and deadwood.
Eligibility Criteria
You may qualify if:
- Living in a detached or terraced house in urban area
You may not qualify if:
- Immunosuppressive medications
- Immune deficiencies
- a disease affecting immune response (e.g., colitis ulcerosa, rheumatoid arthritis, Crohn's disease, diabetes)
- cancer diagnosis within the last year or on-going cancer treatment
- Incompetency
- Living outside city area.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Natural Resources Institute Finlandlead
- Tampere Universitycollaborator
Study Sites (1)
Natural Resources Institute Finland
Helsinki, Uusimaa, 00970, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aki Sinkkonen
Natural Resources Institute Finland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- The research subjects were not randomized or masked to the intervention and control group, because the control group needs volunteers who have no intention of following the yard management instructions advised to the intervention group.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2024
First Posted
April 8, 2024
Study Start
March 30, 2022
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
September 30, 2027
Last Updated
April 8, 2024
Record last verified: 2024-03